Hydrochlorothiazide
- Product NDC
- 68788-7475
- Requested package NDC
- 68788-7475-6
- 11-digit product format
- 687887475
- Labeler code
- 68788
- Product ID
- 68788-7475_8dc0c76e-bafa-456e-83d1-e99f21adb4df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA078164
- Marketing category
- ANDA
- Marketing start
- 2020-02-28
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68788-7475 | 68788-7475-6 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078164-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2007-09-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078164-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078164-001 | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2007-09-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078164-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0 | 2025-04-29 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8242c1de-f482-4a85-b977-610e71fa4904 | 2024-10-07 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 33f9c3ae-108d-469e-af6c-8be3b0f83139 | 2024-09-13 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | e31bd548-29ae-419a-831a-80ebb26e042f | 2024-06-26 | Warnings, Adverse reactions | 078164 ANDA078164 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7475-1 | EA - Each | 68788-7475 | 49e1cea8-09ce-4c78-a7ea-c9ff56bb418b | 1 | 2020-04-20 |
| 68788-7475-3 | EA - Each | 68788-7475 | 4b90e0c4-c6e5-437b-a1d8-8b880172d6db | 1 | 2020-04-20 |
| 68788-7475-6 | EA - Each | 68788-7475 | 86e9793d-90db-4c07-9605-4ab129c01694 | 1 | 2020-04-20 |
| 68788-7475-7 | EA - Each | 68788-7475 | 05756cc2-7ba1-40d1-ad76-024430102c35 | 1 | 2020-04-20 |
| 68788-7475-9 | EA - Each | 68788-7475 | 5aa50f2d-061b-4e46-99c8-e6d0c004fbb7 | 1 | 2020-04-20 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68788-7475-6 | 68788747506 | 60 CAPSULE in 1 BOTTLE (68788-7475-6) | 60 capsule | 2020-02-28 | 0000-00-00 | No | No | Current |